| |
You have received the cancernews.com
email newsletter as per your request. This newsletter is free of charge and you
can remove yourself at any time by
clicking here.
|
 |
|
|
| |
PROSTATE CANCER: URINE TEST CAN PREDICT HIGH-RISK PROSTATE CANCER IN MEN WHO CHOOSE WATCHFUL WAITING
Source: Fred Hutchinson Cancer Research Center (Febuary 2, 2012)
STUDY SHOWS AN INVESTIGATIONAL URINE TEST CAN PREDICT HIGH-RISK PROSTATE CANCER IN MEN WHO CHOOSE ‘WATCHFUL WAITING’
SEATTLE – Initial results of a multicenter study coordinated by researchers at Fred Hutchinson Cancer Research Center indicates that two investigational......[more]
|
 |
| |
Image-guided ablation for Renal Cell Carcinoma: An Update
Renal cell carcinoma (RCC) is a very common clinical problem with an estimated 58,240 patients diagnosed in 2010 [1]. This represents a doubling in the number of RCCs diagnosed in the last 50 years, and a five-fold increase in the diagnosis of small,...[more]
Prostate Cancer: Should active monitoring be used instead of treatment for low risk prostate cancer?
An independent panel convened this week by the National Institutes of Health has concluded that many men with localized, low-risk prostate cancer should be closely monitored, permitting treatment to be delayed until warranted by disease progression....[more]
Relapsed Neuroblastoma: UK starting a phase II clinical trail with new radiotherapy treatment
7 November 2011: A clinical trial is due to start in the UK next year that will offer hope to children who suffer from relapsed neuroblastoma. The UK is the first country to trial the new molecular radiotherapy treatment for treating high-risk neurob...[more]
Chronic Lymphocytic Leukemia Research - Results of DNA study offers clues for future treatments
SAN DIEGO—The most comprehensive search to date of DNA abnormalities in chronic lymphocytic leukemia (CLL) has unearthed several new altered genes that drive this common blood cancer, a finding that could potentially help doctors predict whether an ...[more]
Multiple Myeloma Treatment: Experimental drug combination ‘encouraging’ in relapsed multiple myeloma
SAN DIEGO–When the targeted drug bortezomib stops working in patients with advanced multiple myeloma, the patients survive only an average of five months longer. But a phase 2 clinical trial has shown that pairing bortezomib with an experimental dru...[more]
Sentinel Lymph Node Biopsy: What Breast Cancer Patients Need to Know
Whether or not the cancer has spread to the sentinel lymph node indicates whether the cancer has started to spread beyond the breast. A new technique called sentinel lymph node biopsy identifies this lymph node, and allows only this lymph node to be...[more]
MOLECULARLY TARGETED THERAPY COMBINATION PROVES EFFECTIVE IN FIGHTING A SUBSET OF GASTRIC CANCERS
The drugs Herceptin and Tykerb when given together proved to significantly inhibit tumor growth in gastric cancers that had amplified levels of HER2, a mutation that results in an aggressive form of the disease, causing the cancers to grow and sprea...[more]
Prostate Cancer Research: Hormone independent prostate cancer more likely to spread
Prostate cancers that are resistant to androgen deprivation therapy are more invasive and more likely to spread to other organs than androgen dependent prostate cancers, UCLA cancer researchers have found....[more]
Jobs with increased activity may decrease risk of prostate cancer
Men with jobs that require them to be physically active may be getting benefits beyond salary and health insurance - they may be at a decreased risk of developing prostate cancer, according to a study at UCLA’s Jonsson Cancer Center....[more]
Inflammatory Breast Cancer: Questions and Answers
Inflammatory breast cancer is a rare but very aggressive type of breast cancer in which the cancer cells block the lymph vessels in the skin of the breast. This type of breast cancer is called “inflammatory” because the breast often looks swollen and...[more]
Study Finds Second Breast Cancer Risk Increased by obesity, alcohol consumption and smoking
SEATTLE — Sept. 8, 2009 — It is well known that survivors of breast cancer have a much higher risk of developing a second breast cancer than women in the general population have of developing a first breast cancer. However, little is known about what...[more]
Oral Contraceptives and Cancer Risk
Oral contraceptives (OCs) first became available to American women in the early 1960s. The convenience, effectiveness, and reversibility of action of birth control pills (popularly known as “the pill”) have made them the most popular form of birth co...[more]
Studies find few risks to newborn offspring of parents who are childhood cancer survivors
SEATTLE — Oct 5, 2009 - Whether they can have children is one of the major concerns for adult survivors of childhood and adolescent cancer because fertility can be compromised by cancer treatment. For cancer survivors who can have children, two new s...[more]
Prostate Cancer Prevention Trial
The PCPT was a study designed to see whether the drug finasteride (trade name Proscar®) could prevent prostate cancer in men ages 55 and older. The study began in October 1993 at 221 sites across the United States. The PCPT was expected to continue u...[more]
|
|
|
|
